DK0918776T3 - Totalsyntese af antitumor acylfulvener - Google Patents

Totalsyntese af antitumor acylfulvener

Info

Publication number
DK0918776T3
DK0918776T3 DK97934366T DK97934366T DK0918776T3 DK 0918776 T3 DK0918776 T3 DK 0918776T3 DK 97934366 T DK97934366 T DK 97934366T DK 97934366 T DK97934366 T DK 97934366T DK 0918776 T3 DK0918776 T3 DK 0918776T3
Authority
DK
Denmark
Prior art keywords
acylfulvenes
antitumor
total synthesis
synthesis
total
Prior art date
Application number
DK97934366T
Other languages
Danish (da)
English (en)
Inventor
Trevor C Mcmorris
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0918776T3 publication Critical patent/DK0918776T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/94—Spiro compounds containing "free" spiro atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Organic Insulating Materials (AREA)
  • Inorganic Insulating Materials (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
DK97934366T 1996-08-08 1997-08-05 Totalsyntese af antitumor acylfulvener DK0918776T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/689,461 US5723632A (en) 1996-08-08 1996-08-08 Total synthesis of antitumor acylfulvenes

Publications (1)

Publication Number Publication Date
DK0918776T3 true DK0918776T3 (da) 2004-07-12

Family

ID=24768581

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97934366T DK0918776T3 (da) 1996-08-08 1997-08-05 Totalsyntese af antitumor acylfulvener

Country Status (12)

Country Link
US (6) US5723632A (fr)
EP (2) EP0918776B1 (fr)
JP (1) JP4267702B2 (fr)
AT (1) ATE263771T1 (fr)
AU (1) AU3744397A (fr)
CA (1) CA2262648A1 (fr)
DE (1) DE69728544T2 (fr)
DK (1) DK0918776T3 (fr)
ES (1) ES2215234T3 (fr)
HK (1) HK1019878A1 (fr)
PT (1) PT918776E (fr)
WO (1) WO1998005669A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932553A (en) 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
US6025328A (en) 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents
US7141603B2 (en) * 1999-02-19 2006-11-28 The Regents Of The University California Antitumor agents
US6635490B1 (en) * 2000-05-25 2003-10-21 Noble Laboratories Procedure for the simultaneous quantitative and qualitative analysis of both flavonoid glycosides and steroidal glycosides
DE60121986T2 (de) * 2000-10-02 2007-07-26 Emory University Triptpolidanaloge zur verendung in der behandlung von autoimmunbedingten und entzündlichen erkrankungen
US7015247B2 (en) * 2000-10-12 2006-03-21 Alvin Guttag Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs
US6436916B1 (en) 2000-10-12 2002-08-20 Alvin Guttag Ibuprofen-aspirin and hydroxymethylacylfulvene analogs
CN1269855C (zh) * 2001-06-22 2006-08-16 博里利斯技术公司 含有在4－、5－、6－或7－位被甲硅烷氧基或甲锗烷氧基取代的茚基部分的金属茂催化剂
US7718385B2 (en) * 2003-10-17 2010-05-18 The Johns Hopkins University Bioactivation of alkylating agents for cancer treatment
EP1909783B1 (fr) * 2005-08-03 2011-10-12 The Regents of the University of California Analogues d'illudine utiles en tant qu'agents anticancereux
EP2073807A1 (fr) 2006-10-12 2009-07-01 Astex Therapeutics Limited Combinaisons pharmaceutiques
WO2008044041A1 (fr) 2006-10-12 2008-04-17 Astex Therapeutics Limited Combinaisons pharmaceutiques
EP2148666A4 (fr) * 2007-05-03 2013-05-01 Univ Emory Analogues de fulvène et fulvalène et leur utilisation dans le traitement des cancers
GB0715576D0 (en) * 2007-08-09 2007-09-19 Syngenta Ltd Novel herbicides
WO2009089285A2 (fr) * 2008-01-07 2009-07-16 Emory University Composés diépoxydes ramifiés pour le traitement de troubles inflammatoires
US11135182B2 (en) 2014-04-10 2021-10-05 Af Chemicals, Llc Affinity medicant conjugates
WO2015157578A2 (fr) 2014-04-10 2015-10-15 Af Chemicals, Llc Conjugués de médicament et d'élément d'affinité
US10285955B2 (en) 2014-04-10 2019-05-14 Af Chemicals, Llc Affinity medicant conjugate
CN104650160A (zh) * 2015-01-13 2015-05-27 济南大学 卡培他滨关键中间体1,2,3-o-三乙酰基-5-脱氧-d-核糖的合成新方法
JP7489966B2 (ja) 2018-09-04 2024-05-24 ランタン ファルマ インコーポレイテッド イルジン類似体、それらの使用、およびそれらを合成する方法
EP3667323A1 (fr) 2018-12-11 2020-06-17 Kelner, Michael Procédés, compositions et dispositifs pour le traitement du cancer avec des illudofulvènes
US11591295B2 (en) 2019-11-25 2023-02-28 Af Chemicals Llc Affinity illudofulvene conjugates

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
JPS62234040A (ja) * 1986-04-02 1987-10-14 Kyowa Hakko Kogyo Co Ltd Ｄｃ１０４３物質
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5439936A (en) * 1989-10-03 1995-08-08 The Regents Of The University Of California Method of treating certain tumors using illudin analogs
EP0565519B1 (fr) * 1989-10-03 1996-08-28 The Regents Of The University Of California Analogues d'illudine utiles comme agents antitumoraux
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
ATE213156T1 (de) * 1993-04-27 2002-02-15 Smithkline Beecham Corp Endothelin-rezeptor-antagonisten
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US5932553A (en) * 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) * 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
US6025328A (en) 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents

Also Published As

Publication number Publication date
WO1998005669A1 (fr) 1998-02-12
US6160184A (en) 2000-12-12
CA2262648A1 (fr) 1998-02-12
PT918776E (pt) 2004-07-30
EP0918776A1 (fr) 1999-06-02
US20010029303A1 (en) 2001-10-11
EP1454890A8 (fr) 2004-11-03
HK1019878A1 (en) 2000-03-03
US6469184B2 (en) 2002-10-22
EP1454890A2 (fr) 2004-09-08
EP0918776B1 (fr) 2004-04-07
US6252093B1 (en) 2001-06-26
US5856580A (en) 1999-01-05
AU3744397A (en) 1998-02-25
US20030050495A1 (en) 2003-03-13
US5723632A (en) 1998-03-03
JP2000515552A (ja) 2000-11-21
US6717017B2 (en) 2004-04-06
JP4267702B2 (ja) 2009-05-27
DE69728544T2 (de) 2004-09-16
EP1454890A3 (fr) 2004-11-10
DE69728544D1 (de) 2004-05-13
ES2215234T3 (es) 2004-10-01
ATE263771T1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
BE2018C008I2 (fr)
HK1001963A1 (en) Use of compounds in the preparation of a medicament for the inhibition of a pathological condition
DE69811117D1 (de) Tetrahydrothiopyran-phenyloxazolidinon-s-oxide
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ATE232528T1 (de) Pyrimidinylpyrazolderivate
ATE248814T1 (de) 16-ene-vitamin d derivate
DE69612967D1 (en) Optisch aktive thiazolidinonderivate
DK0850646T3 (da) Liposompræparater af indolocarbazol-derivater
MY130817A (en) Herbicides
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
CA2419463A1 (fr) Intermediaires primaires destines a des colorations capillaires d'oxydation
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
ATE206699T1 (de) Uch-15-verbindungen